The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Bacitracin/Polymyxin B Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the Bacitracin/Polymyxin B ophthalmic shortage in 2026: timeline, prescribing implications, alternatives, and patient access tools.
Aquasol E Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the Aquasol E shortage in 2026. Shortage timeline, prescribing implications, alternative formulations, and tools to help patients.
Arformoterol Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Arformoterol (Brovana) availability in 2026. Coverage of supply status, prescribing considerations, and patient access tools.
Ambien XR Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the Ambien XR (zolpidem ER) shortage in 2026: supply timeline, prescribing implications, alternatives, and tools to help patients.
40,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Abreva Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Abreva (Docosanol) availability in 2026, prescribing implications, alternative treatments, and patient access tools.
Ertaczo Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Ertaczo (Sertaconazole) availability in 2026 — supply status, prescribing implications, alternatives, and patient tools.
Saizen Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Saizen availability in 2026: shortage status, prescribing implications, cost landscape, alternatives, and tools to help patients.
Viloxazine Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Viloxazine (Qelbree) availability in 2026 for healthcare providers. Covers supply chain status, prior authorization, pricing, and tools to help patients access this non-stimulant ADHD medication.
How to Help Your Patients Save Money on Ohtuvayre: A Provider's Guide to Savings Programs
Ohtuvayre costs ~$2,950/month. Here's a provider's guide to all available savings programs — Verona Pathway Plus copay card, Medicare options, patient assistance, and appeal strategies.
Locoid Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Locoid (Hydrocortisone Butyrate) availability in 2026, including prescribing implications, alternatives, and tools to help patients.
Afrezza Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on Afrezza 180 Titration Pack availability in 2026: supply status, prescribing considerations, and patient access tools.
Carac Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on the Carac (Fluorouracil 0.5%) shortage in 2026: timeline, prescribing implications, alternatives, and tools.